αB-crystallin, a member of the small heat shock protein family, has been implicated in various biological functions including response to heat shock, differentiation and apoptosis, the mechanisms of which have not been well understood. Myoblasts, the precursor cells in muscle regeneration, when subjected to growth factor deprivation differentiate to form myotubes or undergo apoptosis. During differentiation, myoblasts express elevated levels of αB-crystallin as well as TNF-α but the connecting link between these proteins in cell signaling is not clearly understood. We have therefore investigated the role of αB-crystallin in TNF-α induced regulation of NF-κB. We demonstrate that in response to TNF-α treatment, αB-crystallin associates with IKKβ and activate its kinase activity, facilitating the degradation of phosphorylated I-kBα, a prime step in NF-κB activation. Reducing the level of αB-crystallin using the RNAi approach reduces the translocation of p65, further confirming the role of αB-crystallin in NF-κB activation. Our study shows that the ability of αB-crystallin to activate NF-κB depends on its phosphorylation status. The present study shows that αB-crystallin-dependent NF-κB activation protects myoblasts from TNF-α induced cytoxicity by enhancing the expression of the antiapoptotic protein, Bcl 2. Thus, our study identifies yet another mechanism by which αB-crystallin exerts its anti-apoptotic activity.
Introduction
Maintenance and survival of cells depends on their ability to cope with the stress conditions. One of the major consequences of stress is the compromised protein function possibly due to its altered conformation. Under conditions of stress, a family of proteins called the heat shock proteins (HSPs), gets up-regulated or activated, which confers protection to the cells [1] [2] [3] . HSPs play a crucial role in maintaining protein homeostasis and are involved in many cellular processes [1] . Small heat shock proteins (sHSPs) function as molecular chaperones in preventing the aggregation of non-native state(s) of proteins and assist in their refolding [4] [5] [6] . These proteins have subunit molecular mass ranging between 12 and 43 kDa and share a conserved domain in their C-terminal region spanning approximately 80-100 amino acid residues called the "alpha-crystallin domain" [7, 8] .
αB-crystallin, a member of small heat shock protein family, is abundantly expressed in eye lens and in many non-lenticular cells such as brain, heart, skeletal muscle, kidney, etc. [9, 10] . It gets up-regulated upon stress and certain pathological conditions such as oxidative stress, heat stress, Alexander's disease, Parkinson's disease, etc. [11, 12] . It has a monomeric mass of 20 kDa and exists as a large oligomer of approximately 600 kDa. Functionally, αB-crystallin acts as a molecular chaperone and prevents the stress-induced aggregation of target proteins [13, 14] . Studies from our laboratory have shown that α-crystallin undergoes structural alteration and displays enhanced chaperone activity at higher temperature [14] [15] [16] . In addition to its chaperone functions, αB-crystallin plays an important role in many cellular events such as proliferation, differentiation and apoptosis [17] [18] [19] .
We have shown that in heat-stressed myoblasts, αB-crystallin associates with F-actin in the cytoplasm and also translocates into the nucleus, where it colocalizes with the lamin A/C network [20, 21] . The association of αB-crystallin with cytoskeletal and nucleoskeletal proteins is suggestive of its cytoprotective function under conditions of stress. A point mutation (R120G) in αB-crystallin results in pathologies such as desmin related myopathy [DRM] in muscle cells, demonstrating its function in muscle maintenance [22, 23] . Studies from our laboratory as well as those from other laboratories indicate that the mutant protein has compromised chaperone activity, which could be the molecular basis of the observed pathology [24] [25] [26] . Moreover, the knockout mice for αB-crystallin die prematurely with extensive muscle wastage, corroborating the importance of αB-crystallin in muscle tissue homeostasis [27] . During muscle differentiation, the level of αB-crystallin is elevated 10-fold, and it plays a critical role in preventing apoptotic cell death induced during the differentiation process [18, 28] . In addition, αB-crystallin has been shown to prevent cell death induced upon oxidative stress as well as staurosporin and doxorubicin treatment [19, [29] [30] [31] . Various studies show that αB-crystallin interacts directly with Bax and Bcl Xs and prevents apoptosis by inhibiting their translocation into mitochondria [30] . Further, αB-crystallin has been found to inhibit maturation/ activation of executor caspases such as caspase-3 and -8 in response to TNF-α treatment, thus preventing cellular responses to death signals [31] .
TNF-α is an inflammatory cytokine produced by immune cells and muscle cells during development and strenuous exercise or injury [32] [33] [34] . Besides the known role as an inducer of inflammation, cachexia and cytotoxicity, TNF-α is essential for muscle tissue homeostasis as injecting antibodies or knocking out TNF-α or its receptor, results in mice with lower muscle mass [32] [33] [34] . TNF-α acts as a mitogen in skeletal muscle [33, 35] and is involved in modulating the activity of NF-κB, a ubiquitous transcription factor that in turn regulates the expression of many genes in a condition-dependent manner [36] . NF-κB has been shown to be associated in many cellular processes such as growth, differentiation, inflammation, apoptosis and stress response [37] . However, an aberrantly active NF-κB could lead to chronic or excessive inflammation associated with diseases such as rheumatoid arthritis, asthma, etc. [37] [38] [39] [40] . Therefore, NF-κB, being a central transcription factor needs to be modulated precisely to perform its function.
Expression of αB-crystallin and TNF-α is reported to increase in response to stress and differentiation [18, 29, 33] ; however, prolonged exposure to TNF-α has cytotoxic effects. The relation between the elevated expression of αB-crystallin and TNF-α, if any, is not understood. We have investigated the effect of αB-crystallin, if any, on TNF-α-induced modulation of NF-κB activation as well as cell survival in C2C12 mouse myoblasts. Our study shows that αB-crystallin promotes NF-κB activation, in a phosphorylation-dependent manner, and protects myoblasts against TNF-α induced cytotoxicity. This study also brings out another pathway by which αB-crystallin exerts its anti-apoptotic effect.
Experimental

Cell culture and reagents
DMEM, fetal calf serum (FCS), anti-FLAG antibody (M2 clone), and cycloheximide were purchased from Sigma Chemical Company, USA. Kinase inhibitors, SB202190 (p38-MAP kinase) and PD098059 (p44-MAP kinase), and TNF-α were obtained from Calbiochem, EMD Biosciences Inc. Germany. Propidium iodide (PI), Alexa-488-and Cy3-conjugated secondary antibodies were obtained from Molecular Probes, Invitrogen Corp.,OR, USA. Anti-actin mouse monoclonal antibodies were purchased from Chemicon International Inc., USA. Rabbit anti-IKKα/β, mouse anti-IKKβ, rabbit anti-β-tubulin, rabbit anti-IκBα, mouse anti-phospho-IκBα and rabbit anti-p65 antibodies were purchased from Santa Cruz, USA. Mouse monoclonal anti-αB-crystallin, rabbit polyclonal anti-αB-crystallin and rabbit polyclonal Ser-59-αB-crystallin antibodies were purchased from Stressgen, Victoria, Canada. Mouse monoclonal anti-Bcl 2 antibodies were purchased from BD Biosciences, USA. Monoclonal anti-HA antibodies and protease inhibitor cocktail were procured from Roche Applied Sciences, USA. Lipofectamine-2000 was procured from Invitrogen, USA. HRPO-conjugated secondary antibodies and enhanced chemiluminescence (ECL) Western blot detection kit were obtained from Amersham Biosciences, USA. Vectashield mounting medium containing DAPI was purchased from Vector Laboratories, USA.
Mouse skeletal myoblast cell line C2C12 was maintained at subconfluent densities (60-70%) in DMEM supplemented with 20% fetal calf serum at 37°C in a humidified atmosphere containing 5% CO 2 .
Plasmids and construction of FLAG-tagged cDNAs
The full-length cDNAs of αB-crystallin and R120G-αB-crystallin were PCR-amplified using the following primers: forward primer-5′-GGCCGAATTCATGGACATCGCCATCCACCAC-3′ and reverse primer-5′-GCCCTCGAGCTATTTCTTGGGGGCTGCGG-3′. The PCR products were digested with EcoR1 and Xho1 restriction enzyme and ligated into a modified pCDNA3 vector in which the FLAG epitope was inserted upstream of the multiple cloning site and confirmed by automated DNA sequencing. pEGFP vector was procured from Clontech laboratories Inc., USA. The plasmid pCDNA 3.1 HA-3A αB-crystallin (hemagglutin tagged αB-crystallin, where serine residues at 19, 45 and 59 position were replaced with alanine, thus mimicking a nonphosphorylable mutant form), which was provided by Dr. C.C. Glembotski, SDSU Heart Institute and Department of Biology, San Diego, USA. The pSUPER vector and pRNAi-αB-crystallin were provided by Dr. V. Cryns, Departments of Medicine and Cell and Molecular Biology, Northwestern University, Chicago, USA.
Stable and transient transfections
For stable transfections, C2C12 cells grown in six-well plate were transfected with 1μg of pcDNA3-N FLAG plasmids or control vector pEGFP-N1 using Lipofectamine 2000 reagent following the manufacturer's protocol. Stably transfected cells were selected using G418 (geneticin) and single cell clones expressing approximately 2-fold higher levels of αB-crystallin or R120G-αB-crystallin (Western blot analysis done using FLAG-specific antibodies) were selected, expanded and used for our study.
For NF-κB reporter gene assay experiments, 400 ng of NF-κB reporter plasmid, HIV LTR-luciferase (containing three NF-κB binding sites) [38] , along with 75 ng of pCMV β-gal reporter plasmid were transfected using Lipofectamine 2000. The cells, 24 h post-transfection, were treated with TNF-α (20 ng/ml) for 6 h. Reporter gene activity was determined with the luciferase assay kit [Promega, Madison, USA]. β-Galactosidase activity was used to normalize the transfection efficiency. In some experiments, the cells were treated with either DMSO (vehicle) or 20 μM SB202190 (p38-MAPK inhibitor) for 6 h and subsequently treated with TNF-α.
For investigating the effect of silencing of αB-crystallin on nuclear translocation of NF-κB, C2C12, CRYAB-C2C12 and R120G-C2C12 cells were co-transfected with pRNAi-αB plasmid and pGFP-V-RS vector (Origene Technologies Inc., USA, which contained puromycin resistance Fig. 1 . Luciferase reporter gene assay for NF-κB. C2C12, CRYAB-C2C12 and R120G-C2C12 cells were transiently transfected with NF-κB reporter plasmid as described in Section 2. 24 hpost-transfection, the cells were treated with TNF-α [20 ng/mL] for 6 h and the luciferase activity was measured. Transfection efficiency was normalized using β-galactosidase expression assay. The bar diagram represents fold change in luciferase activity of TNF-α-treated C2C12 cells and of untreated or TNF-α-treated CRYAB-C2C12 or R120G-C2C12 cells over that observed in untreated C2C12 cells. gene) at a ratio of 6:1, respectively. The cells were selected with 2 μg/mL of puromycin for 5 days and subsequently with 0.5 μg/mL for another 3 days. The total cell lysate and the isolated nuclei from knockout pool of cells were used for Western blot analysis.
Isolation of nuclei
For isolation of nuclei, 3-4 million cells were harvested using the non-enzymatic cell dissociation solution. After washing twice with PBS, cells were resuspended in low-salt buffer (10 mM HEPES, pH 7.4, 10 mM KCl, 0.5 mM EDTA, 0.1 mM EGTA, 0.1 mM DTT, 2 mM phenyl methyl sulfonyl fluoride (PMSF), and the protease inhibitor cocktail (Roche). After 10 min on ice, cells were passed through 20 gauge needle 4-5 times to dislodge the clumps and then ruptured by passing through a 26 gauge needle. The enrichment of nuclei was achieved by sedimentation of crude nuclear pellet through 300 mM-sucrose cushions at 400 × g. The isolated nuclei were lysed by freeze-thaw method.
Immunofluorescence microscopy
C2C12 and CRYAB-C2C12 cells were grown on cover slips and transfected with HA-3A αB-crystallin mutant using Lipofectamine reagent according to the manufacturer's protocol. For the RNAi experiments, cells were co-transfected with pRNAi-αB plasmid and pEGFP vector. Cells were then treated with TNF-α for indicated time points, washed twice with PBS and fixed with 3.7% formaldehyde. The fixed cells were permeabilized with 0.05% Triton X-100 for 8 min. After blocking with 2% BSA, cells were incubated overnight with anti-HA monoclonal antibodies and anti-p65 rabbit polyclonal antibodies. The cover slips were then washed with PBS and further incubated with anti-mouse Ig-Alexa-488 or anti-rabbit Ig-Cy3-tagged secondary antibodies. The cells were mounted in Vectashield medium containing DAPI. Confocal laser scanning microscopy was performed on a Carl Zeiss inverted microscope. Image analysis was done using LSM 510meta software (Version 5).
SDS-PAGE and Western blot analysis
C2C12, CRYAB-C2C12 and R120G-C2C12 cells were treated with TNF-α and harvested at indicated time points. Cells were lysed in icecold lysis buffer containing 20 mM HEPES, pH 7.5 containing 50 mM NaCl, 1 mM EDTA, 30 mM NaF, 2 mM Na 3 VO 4, 0.5 mM PMSF, 0.1% Nonidet-P40, and protease inhibitor cocktail, sonicated and centrifuged at 20,800 × g for 10 min at 4°C. Protein estimations were done using BCA kit. Equal amount of proteins were electrophoresed on 12% SDS-polyacrylamide gels and transferred to nitrocellulose membrane using semi-dry transfer apparatus (Millipore, USA). The membrane was blocked with 10% milk protein and sequentially incubated with appropriate primary antibodies and HRPO-conjugated secondary antibodies and visualized using Amersham-Pharmacia ECL detection kit.
Inhibitor kappa kinase (IKK) assay
Cells were treated with 20 ng/ml of TNF-α for 10 min and then cells were lysed using buffer containing 50 mM Tris-HCl buffer (pH 7.4) containing 50 mM NaCl, 5 mM EDTA, 50 mM NaF, 1 mM PMSF, 0.2 mM Na 3 VO 4 , 0.2% NP40, 10% glycerol (IP buffer). In some experiments, the cells were treated with 20 μM SB202190, for 6 h. Total cell lysates (500 μg of protein) were incubated with anti-IKKα/β antibody and then immunoprecipitated using Protein-G beads. The beads were washed twice and incubated in kinase reaction buffer (20 mM HEPES, pH 7.5 containing 5 mM MgCl 2 , 25 mM β-glycerophosphate, 1 mM sodium orthovanadate, 100 mM NaF, 1 mM dithiothreitol) 10 μM disodium ATP and 0.5 μCi of [γ- 32 P] ATP and 100 ng of recombinant IκBα and incubated for 30 min at 30°C. The reaction was terminated using Laemmli sample buffer and the proteins were resolved by 15% SDS-PAGE. Radioactivity was detected by phospho-imaging and quantitated by densitometry using GeneTool software.
Immunoprecipitation and Western blot analyses
C2C12, CRYAB-C2C12 and R120G-C2C12 cells were treated with or without TNF-α (20 ng/ml) for 30 min. The cells were lysed by sonication with two pulses of 10 s duration, in IP buffer. The total cell extracts (750 μg to 1 mg of protein) were incubated with 1 μg of anti-IKKα/β antibody or αB-crystallin antibodies overnight at 4°C. Subsequently, protein-G magnetic beads were added to these samples and they were incubated further for 4 h. The magnetic bead complex was retrieved using a magnetic separator kit (Bangs Laboratories Inc., USA). The immunoprecipitated complex was washed thrice with icecold IP buffer and suspended in Laemmli buffer. The samples were heated in a boiling water bath for 5 min and subjected to SDS-PAGE. The proteins were transferred onto a nitrocellulose paper (Hybond C, Amersham Biosciences, Sweden), probed using specific antibodies as indicated and then visualized using ECL system.
Induction of apoptosis
Apoptosis was induced in normal C2C12 cells, CRYAB-C2C12 and R120G-C2C12 cells by treatment with 100 ng/ml TNF-α for 18 h. In some experiments, cells were treated with 20 μM SB202190 or the vehicle-DMSO alone for 6 h prior to TNF-α treatment. At the end of the treatment, the cells were fixed in 80% methanol, stained with propidium iodide and analyzed by using Fluorescence Activated Cell Sorter (FACS-Caliber, Becton and Dickinson, USA). The percent of sub-G1 population that represents apoptotic cells was estimated. The values represent an average of three independent experiments and are expressed as percentage.
Results
αB-crystallin promotes DNA-binding and transcriptional activity of NF-κB
Serum starvation induces elevated levels of αB-crystallin as well as TNF-α C2C12 myoblasts [18, 33] . However, prolonged exposure of cells to this cytokine induces cell death [41] . The relation between the elevated expression of αB-crystallin and TNF-α, if any, is not understood. Since TNF-α is known to modulate NF-κB activity, we have investigated NF-κB activation upon treating normal, CRYAB-C2C12 and R120G-C2C12 cells with TNF-α, using luciferase reporter assay (Fig. 1) . In the absence of TNF-α, CRYAB-C2C12 cells showed 1.5-fold higher luciferase activity compared to C2C12 cells. Upon TNF-α treatment for 6 h, C2C12 cells showed 4-to 5-fold enhanced luciferase activity compared to untreated cells (Fig. 1) . Interestingly, TNF-α treatment of CRYAB-C2C12 cells resulted in 10-to 11-fold increase in luciferase activity with respect to untreated C2C12 cells and about 6-to 7-fold increase with respect to untreated CRYAB-C2C12 cells (Fig. 1) . The cells expressing the functionally compromised R120G mutant of αB-crystallin exhibit luciferase activity comparable to that of the respective controls of C2C12 cells either in the absence or in the presence of TNFα (Fig. 1) . Thus, the luciferase reporter assay clearly indicates that αB-crystallin but not R120GαB-crystallin promotes the functional activation of NF-κB upon treating the myoblasts with TNFα.
Nuclear translocation is the prime step in the activation of NF-κB [37] [38] [39] [40] . We further confirmed the activation of NF-κB by Western blot analysis of p65 using nuclear lysates. Upon treatment with TNF-α, the nuclear levels of p65 in C2C12 cells is increased to 1.5-fold compared to untreated cells ( Fig. 2A) . It is important to note that, in untreated CRYAB-C2C12 cells, the level of nuclear p65 was comparable to that in TNF-α treated C2C12 cells, which further increased by 2.5-fold upon TNF-α treatment as compared to parental C2C12 cells. Interestingly, we find that the nuclear level of p65 in R120G-C2C12 cells (untreated as well as TNF-α treated) is found to be comparable to C2C12 cells treated with TNF-α. In addition, the nuclear p65 levels in R120G-C2C12 cells did not change significantly before and after TNF-α treatment ( Fig. 2A) . To further validate our data, we performed immunostaining of p65 in C2C12, CRYAB-C2C12 and R120G-C2C12 cells before and after TNF-α treatment. In the absence of TNF-α, p65 staining showed mostly cytoplasmic localization, while upon treatment, p65 gets translocated to the nucleus (Fig. 2B) . Upon TNF-α treatment, the staining for p65 in C2C12 cells was seen both in the cytoplasm and the nucleus, whereas in CRYAB-C2C12 cells, a significant fraction of p65 was in the nucleus with very little or no staining in the cytoplasm (Fig. 2B) . Interestingly, we observe that the staining pattern is very much different in R120G-C2C12 cells as compared to both parental C2C12 and CRYAB-C2C12 cells. In these cells, the staining pattern of p65 is diffuse, while in R120G-C2C12 cells, nuclear p65 has speckled appearance (Fig. 2B) . Moreover, the nuclear accumulation of p65 in R120G-C2C12 cells did not change (with or without TNF-α treatment), thus supporting our Western blot data ( Fig. 2A) . Our investigations using gel shift assay show an enhanced DNA-binding ability of NF-κB in nuclear extracts from CRYAB-C2C12 cells compared to parental C2C12 cells, suggesting that αB-crystallin increases the promoter activity of NF-κB (data not shown).
Taken together, our results suggest that αB-crystallin enhances the nuclear translocation and the transcriptional activity of NF-κB upon TNF-α treatment.
3.2. RNAi-mediated decrease in αB-crystallin level reduces nuclear translocation of NF-κB C2C12 and CRYAB-C2C12 cells were transiently transfected either with pSUPER vector (control) or with pRNAi for αB-crystallin, using Lipofectamine. In our experimental conditions, we observed a transfection efficiency of approximately 25-30%. We observed a large reduction in the level of αB-crystallin with the pRNAi-αB plasmid but not with pSUPER vector, whereas the expression of another small heat shock protein, HSP25, was unaffected by the transfection of both the plasmids (Fig. 3A) . Densitometric analysis using Image J (NIH, USA) software, we achieved a knockdown of αB-crystallin expression by 62%. After 24 h of transfection, C2C12 and CRYAB-C2C12 cells were treated with TNF-α (20 ng/ml) for 6 h and Western blot analysis was performed for p65 in the nuclear fractions. Our Western blot data clearly show that upon TNF-α treatment there is marked decrease in the level of nuclear p65 in (Fig. 3B). 3.2.1. Immunolocalization experiments were also for p65 in normal and RNAi-mediated αB-crystallin knocked down cells upon TNF-α treatment Our confocal data show that the cells transfected with pSUPER vector display nuclear staining of p65 in C2C12 as well as in CRYAB-C2C12 cells (Fig. 3C) . It is important to mention here that, in CRYAB-C2C12 cells, the staining of p65 was much more intense in the nucleus than in the cytoplasm, whereas in C2C12 cells both cytoplasmic and nuclear staining was of similar intensity. The nuclear to cytoplasmic ratio of the mean intensities of p65 in untransfected cells and in cells transfected with pSUPER vector alone was 1.45, suggesting that transfection per se does not alter the localization of p65. Importantly, we find that the nuclear-cytoplasmic ratio of the mean intensities of p65 is reduced to 0.74 in the cells transfected with pRNAi-αB construct, indicating that reducing the levels of αB-crystallin significantly reduces the nuclear translocation of p65. Similarly, in CRYAB-C2C12 cells, the nuclear-cytoplasmic ratio of the mean intensities of p65 was found to be 1.74 in pSUPER vector alone transfected cells, which reduces to 0.72 in cells transfected with the pRNAi-αB construct. In support of the Western blot data, we found that upon knocking down the levels of αB-crystallin by pRNAi, the nuclear translocation of p65 decreased dramatically and it was completely localized to the cytoplasm (Fig. 3C ). Taken together, our Western blot and confocal analysis results show that reduction of αB-crystallin levels leads to decreased nuclear translocation of NF-κB, and therefore its activity. These observations confirm the specific role of αB-crystallin in modulating nuclear translocation of NF-κB, thereby regulating its TNF-α-induced activation.
αB-crystallin enhances phosphorylation and subsequent degradation of IκBα
In order to understand the mechanism of NF-κB activation by αB-crystallin, we have analyzed the phosphorylation status and the levels of the Inhibitor κB-α (I-κBα). I-κBα is bound to the p65-p50 complex of NF-κB, keeping it in an inactive form by masking the nuclear translocation signal [40] , thereby causing its cytoplasmic retention and blocking both its DNA-binding and transactivation abilities. Phosphorylation of I-κBα at serine residues 32 and 36 releases it from the complex, followed by its subsequent degradation by the 26S proteosome [42, 43] . Using Western blot analysis, we have investigated the levels and phosphorylation status of I-κBα in C2C12, CRYAB-C2C12 and R120G-C2C12 cells upon TNF-α treatment. The levels of phosphorylated I-κBα in C2C12 cells treated with TNF-α increased by 2.2-fold as compared to untreated cells (Fig. 4A) . Importantly, the levels of phosphorylated I-κBα in untreated CRYAB-C2C12 cells were comparable to those of TNF-α treated C2C12 cells. Moreover, the phosphorylation of I-κBα in CRYAB-C2C12 cells increased significantly (3.7-fold) upon TNF-α treatment. Interestingly, the phosphorylation level of I-κBα in R120G-C2C12 cells was slightly less than that in the control C2C12 cells, and did not change after treatment with TNF-α (Fig. 4A) .
The phosphorylation of I-κBα renders it susceptible to degradation [43] . In order to monitor the degradation of I-κBα, we have carried out Western blot analysis. In the absence of TNF-α treatment, the levels of I-κBα were less in case of CRYAB-C2C12 cells than in C2C12 and R120G-C2C12 cells (Fig. 4B) . Upon TNF-α treatment, there was further decrease in I-κBα levels in CRYAB-C2C12 cells, which was even less than that in normal C2C12 cells treated with TNF-α. There was no significant change in I-κBα levels in R120G-C2C12 cells after TNF-α treatment (Fig. 4B) . This suggests that αB-crystallin enhances the degradation of I-κBα, a key regulatory step involved in the activation and nuclear translocation of NF κB.
αB-crystallin enhances the kinase activity of IKK complex
To elucidate the mechanism by which αB-crystallin enhances the phosphorylation of I-κBα and its subsequent degradation, we investigated the kinases that are responsible for the phosphorylation of I-κBα. IKKβ, the predominant kinase of the IKK complex, is involved in phosphorylation of I-κBα [42] . The IKK complex was immunoprecipitated from the lysates of control or TNF-α-treated C2C12, CRYAB-C2C12 and R120G-C2C12 cells. Under normal condition, the kinase activity of immune complex of C2C12 and R120G-C2C12 cells was comparable, whereas that of CRYAB-C2C12 cells was~2-fold higher as compared to parental cells (Fig. 5A) . Upon TNF-α treatment, normal C2C12 cells showed~2-fold increased kinase activity, while CRYAB-C2C12 exhibited 4-fold increase in kinase activity to that of untreated parental cells. Surprisingly, R120G-C2C12 showed a decrease in the kinase activity upon TNF-α treatment compared to untreated C2C12 or CRYAB-C2C12 cells (Fig. 5A) . These results suggest that over-expression of αB-crystallin results in a specific increase in the kinase activity of the IKK complex.
αB-crystallin interacts with the IKK complex
The enhancement in the kinase activity in CRYAB-C2C12 cells prompted us to investigate the possible interaction of αB-crystallin with the IKK complex. Normal C2C12, CRYAB-C2C12 and R120G-C2C12 cells were treated with TNF-α [20 ng/ml] for 30 min. Immunoprecipitation was performed using antibodies specific to αB-crystallin and Western blot was performed using IKK antibodies. The interaction of IKK with αB-crystallin that was faintly detectable in untreated C2C12 cells is evident in TNF-α-treated C2C12 cells (Fig. 5B) . The interaction of IKK with αB-crystallin was significant in CRYAB-C2C12 cells in the untreated condition (Fig. 5B) , which further increases upon treatment with TNF-α. The interaction of IKK complex with αB-crystallin was further confirmed by reverse immunoprecipitation using IKKα/β-specific antibodies (data not shown). Thus, our study suggests that association of αB-crystallin with the IKK complex results in increase in its kinase activity.
Effects of TNF-α on the expression and phosphorylation of αB-crystallin
In order to study the effect of TNF-α on the expression of αB-crystallin, C2C12, CRYAB-C2C12 and R120G-C2C12 cells were treated with TNF-α and the cell lysate was probed with antibodies specific for αB-crystallin. Upon treatment with TNF-α in C2C12 cells, there is an increase in the αB-crystallin level. We observed no significant change in αB-crystallin levels upon TNF-α treatment in CRYAB-C2C12 cells or in R120G-C2C12 cells [ Fig. 6A ]. It is possible that the increased expression of αB-crystallin in CRYAB-C2C12 cells is sufficient to counter cytotoxic effects of TNF-α.
It is well-known that TNF-α treatment activates p38-MAP kinase [44] ; it is also known that p38-MAP kinase is involved in the phosphorylation of αB-crystallin at Ser-59 residue under stress conditions [45, 46] . Phosphorylation of αB-crystallin plays an important role in modulating its activity, localization, interaction with other proteins and its cellular functions [47] [48] [49] . Western blot analysis using Ser-59 phospho-specific antibodies shows that TNF-α treatment increases phosphorylation of αB-crystallin in C2C12 cells (Fig. 6B) . In untreated CRYAB-C2C12 cells, we observed an enhanced phosphorylation at the Ser-59 residue compared to untreated C2C12 cells, which further increased upon TNF-α treatment (Fig. 6B) . Compared to the normal C2C12 cells, untreated R120G-C2C12 cells showed hyper-phosphorylation of αB-crystallin, which surprisingly decreases upon TNF-α treatment (Fig. 6B) .
Phosphorylation of αB-crystallin at Ser-59 residue enhances NF-κB activity
Since our results show increase in the Ser-59 phosphorylation of αB-crystallin upon TNF-α treatment, we have investigated the importance of Ser-59 phosphorylated αB-crystallin on the activation of NF-κB using luciferase reporter assay (Fig. 7A) . We find that upon inhibiting αB-crystallin phosphorylation at Ser-59 residue using p38-MAP kinase inhibitor (SB202190) the activation of NF-κB is reduced in both C2C12 as well as in CRYAB-C2C12 cells, suggesting that Ser-59 phosphorylation is critical for its activation (Fig. 7A) . Interestingly, in R120G-C2C12 cells, there is no appreciable change in NF-κB activity.
It is possible that the p38-MAP kinase inhibitor, SB202190, though selective, might have some unintended inhibitory effects on other kinases as well. To rule out this possibility, we have transiently transfected C2C12 cells with either the vector alone or the HA-3A-αBcrystallin mutant followed by TNF-α treatment. Immunolocalization and confocal microscopic analyses (Fig. 7B) show that upon TNF-α treatment, the translocation of p65 is severely affected in HA-3A-αBcrystallin expressing cells (shown by star) as compared to parental cells (shown by arrow). We find that in the absence of TNF-α, the nuclear to cytoplasmic mean intensity ratio of p65 is 0.57 in both parental as well as HA-3A-αBcrystallin transfected cells, suggesting that transfection per se does not affect the cellular localization of p65. It is noteworthy that after TNF-α treatment, the nuclear to cytoplasmic ratio of p65 in untransfected cells is increased to 1.12, whereas it remained practically unchanged (0.62) in cells transfected with HA-3A-αBcrystallin mutant. Thus our analysis shows that phosphorylation of αB-crystallin plays an important role in the nuclear translocation of p65. 3.8. Ser-59 phosphorylation of αB-crystallin is required for kinase activation but not for the interaction with IKK complex
In order to investigate whether Ser-59 phosphorylation of αB-crystallin influences the interaction and activation of IKK complex, we have treated C2C12 and CRYAB-C2C12 cells with p38-MAP kinase inhibitor (SB202190) followed by TNF-α treatment. Cell lysates were immunoprecipitated with antibodies specific to αB-crystallin and immunoblotted with antibodies specific to IKKβ or αB-crystallin. We did not observe significant difference in interaction of αB-crystallin with the IKK complex even when cells were treated with SB202190 (Fig. 8A) . This suggests that the association between αB-crystallin and IKK complex is not dependent on the phosphorylation of αB-crystallin. To investigate whether Ser-59 phosphorylation of αB-crystallin has any influence on IKK kinase activity, we performed the kinase activity of the immunoprecipitates obtained from cell lysates described above. We observed a significant decrease in the kinase activity in both the normal C2C12 and CRYAB-C2C12 cells treated with SB202190 (Fig. 8B) . Taken together, our data show that Ser-59 phosphorylation of αB-crystallin is not essential for its association with the IKK complex, but appears to be important for the enhancement of its kinase activity.
3.9. Enhanced activation of NF-κB leads to increased protection in cells over-expressing αB-crystallin NF-κB is known to be involved in processes that lead to proapoptotic or anti-apoptotic cellular responses [39, 50] . To find out the effect of αB-crystallin induced NF-κB activation, C2C12, CRYAB-C2C12 and R120G-C2C12 cells were fixed in 80% ethanol, stained with propidium iodide (PI) and analyzed by fluorescence activated cell sorter (FACS). FACS analysis showed that~5% of the normal untreated C2C12 cells underwent cell death (Fig. 9A) . The extent of cell death was not significantly different in CRYAB-C2C12 cells, whereas it was higher in R120G-C2C12 cells. Upon treatment of C2C12 cells with TNF-α, there was a significant increase in cell death (~65%). Interestingly, CRYAB-C2C12 cells showed almost no increase in cell death upon similar treatment. This suggests that over-expression of αB-crystallin contributes significantly in its protection of cells to TNF-α-induced cell death. In the case of R120G-C2C12 cells, TNF-α treatment leads to increase in cell death, which is approximately 42% (Fig. 9A) . Interestingly, when the cells were treated p38-MAP kinase inhibitor, SB202190, and subsequently with TNF-α, there was significant increase in cell death in C2C12, CRYAB-C2C12 and R120G-C2C12 cells suggesting loss of cytoprotective ability of αB-crystallin (Fig. 9B) . Thus far our data show that αB-crystallin enhances the NF-κB activity and prevents TNF-α-induced cell death in a phosphorylation-dependent manner.
To further elucidate the downstream functions of NF-κB, we performed Western blot for Bcl 2, a key anti-apoptotic protein, which is a known target of NF-κB [46, 47] . Our Western blot analysis shows that there is increased expression of Bcl 2 protein in CRYAB-C2C12 cells, whereas in C2C12 or R120G-C2C12 cells, the increase is marginal (Fig. 10A, B) . This suggests that by activation of NF-κB, αB-crystallin modulates the cell death pathway, thus preventing TNF-α induced cell death.
Discussion
Small HSPs are constitutively expressed in several tissues including skeletal muscles, where they confer stress tolerance [10, 11] . Skeletal muscles are constantly subjected to injury or stress and require repair and regeneration to maintain tissue homeostasis. Transgenic mice lacking the expression of αB-crystallin suffered severe muscle wastage and premature death [27] . Interestingly, mice knocked out for TNF-α or its receptor associated factor-TRAF2 result in animals with smaller muscle mass [32] . During conditions of stress, growth factor deprivation and muscle differentiation, expression of both TNF-α, as well as the small heat shock protein, αB-crystallin, has been reported to be elevated [18, 33] . It is also documented that prolonged exposure to high concentrations of TNF-α induces cell death [41] . However, the role of αB-crystallin in TNF-α signaling, if any, is not known. TNF-α is a known activator of NF-κB, a ubiquitously expressed transcription factor, whose target genes regulate division and death in several cell types.
To investigate the role of αB-crystallin in the activation of NF-κB pathway, we have used two approaches (i) induced expression of either αB-crystallin or its functionally compromised mutant-R120GαB-crystallin or (ii) RNAi-mediated reduction in the levels of αB-crystallin. Our investigations have revealed that increased expression of wild type αB-crystallin enhances NF-κB activity. On the other hand, increased expression of dominant negative mutant-R120GαB-crystallin or RNAi-mediated reduction of αB-crystallin negatively modulates NF-κB activity. The underlying mechanism in this process of NF-κB regulation is schematically presented in Fig. 11 . Upon TNF-α treatment, αB-crystallin associates with IKKβ and enhances its kinase activity, which leads to phosphorylation and subsequent degradation of IκB-α, a negative regulator of NF-κB activity. Degradation of IκBα facilitates nuclear translocation and enhances the transcription of Bcl 2, a known target of NF-κB. Bcl 2 is an anti-apoptotic protein and hence protects the cells from TNF-α induced cytotoxicity.
Phosphorylation of αB-crystallin at Ser-59 residue appears to be essential in the activation NF-κB. TNF-α has earlier been shown to activate p38-MAP kinase [44] . The p38 MAP kinase is known to phosphorylate αB-crystallin at Ser-59 residue [49] . Though Ser-59 phosphorylation is not required for association of αB-crystallin with the IKK complex, it is essential for enhancing the kinase activity of IKβ.
Hsp 27, another closely related member of the small heat shock protein family, has also been shown to negatively or positively regulate NF-κB activity. It associates with IKKβ and negatively regulates NF-κB activity [51, 52] , or facilitates IκB-α degradation, thereby enhancing NF-κB activity [53] . These observations suggest that though both αB-crystallin and Hsp 27 share sequence homology and belong to the small heat shock protein family, they function in different ways in the regulation of NF-κB activity.
NF-κB regulates the expression of genes involved in diverse biological events such as growth, differentiation and cell death [37] [38] [39] [40] . We observed that activation of NF-κB by αB-crystallin actually enhances the expression level of the anti-apoptotic protein, Bcl 2. This is the first report to demonstrate the activation of NF-κB by αB-crystallin, which in turn enhances the expression levels of Bcl 2 and confers cytoprotection. Fig. 11 also schematically depicts the other reported mechanisms by which αB-crystallin inhibits apoptosis in cells. Importantly, it prevents caspase 3 maturation and activity, thereby inhibiting apoptosis; it also protects mitochondrial integrity by preventing the translocation of Bax and Bcl Xs to the mitochondria [30] . A careful scrutiny of mechanisms reported earlier by which αB-crystallin prevents cell death reveals inhibition of pro-apoptotic molecules such as caspase 9, caspase 3 as a key event in this process. In addition to these mechanisms, we propose yet another mechanism by which αB-crystallin indirectly elevates the levels of anti-apoptotic proteins and thereby prevents cell death.
